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Use of the prevented fraction for the population to 
determine deaths averted by existing prevalence of physical 
activity: a descriptive study
Tessa Strain, Søren Brage, Stephen J Sharp, Justin Richards, Marko Tainio, Ding Ding, Jacques Benichou, Paul Kelly
Summary
Background Disease and mortality burdens of unhealthy lifestyle behaviours are often reported. In contrast, the 
positive narrative around the burdens that an existing behaviour have averted is rarely acknowledged. We aimed to 
estimate the prevented fraction for the population (PFP) for premature mortality averted by physical activity on a 
global scale.
Methods In this descriptive study, we obtained previously published data on physical activity prevalence (2001–16) and 
relative risks of all-cause mortality for 168 countries. We combined the data in Monte-Carlo simulations to estimate 
country-specific, mean PFP values, corresponding to percentage of mortality averted, and their 95% CIs. High prevented 
fractions indicated an increased proportion of deaths averted due to physical activity. Using mortality data for all people 
in a country aged 40–74 years, we estimated the number of premature deaths averted for all adults and by gender. We 
present the median and range of the prevented fractions globally, by WHO region, and by World Bank income 
classification.
Findings The global median PFP was 15·0% (range 6·6–20·5), conservatively equating to 3·9 million (95% CI 
2·5–5·6) premature deaths averted annually. The African region had the highest median prevented fraction (16·6% 
[range 12·1–20·5]) and the Americas had the lowest (13·1% [10·8–16·6]). Low-income countries tended to have higher 
prevented fractions (group median 17·9% [12·3–20·5]) than high-income countries (14·1% [6·6–17·8]). Globally, the 
median prevented fraction was higher for men (16·0% [7·8–20·7] than women (14·1% [5·0–20·4]).
Interpretation Existing physical activity prevalence has contributed to averting premature mortality across all 
countries. PFP has utility as an advocacy tool to promote healthy lifestyle behaviours. By making the case of what has 
been achieved, the prevented fraction can show the value of current investment and services, which might be 
conducive to political support.
Funding UK Medical Research Council, British Heart Foundation, Cancer Research UK, Economic and Social 
Research Council, National Institute for Health Research, Wellcome Trust, Heart Foundation Australia. 
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction
When making the case for the promotion of healthy 
lifestyle behaviours, statistics that quantify the burden 
of reciprocal unhealthy behaviours are often cited.1–3 For 
example, physical inactivity is responsible for 6·4% of 
global premature mortality, insufficient fruit and vegetable 
consumption for 11·3%, and harmful alcohol consumption 
for 5·3%;3–5 although methodological differences can lead 
to substantially different results.6,7 Some researchers 
advocate that stressing the harms of unhealthy behaviours 
can strengthen the case in promoting healthy lifestyles.8 
We suggest that an alternative strategy is to present 
the complementary positive, gain-framed message that 
clarifies to what extent existing healthy behaviours have 
already reduced burdens of disease and mortality.9
In this Article, we describe and explore the use of 
the prevented fraction for the population (PFP), defined 
as the proportion of a disease outcome or mortality that 
has been averted or prevented due to the presence 
of a protective factor (panel).10 This is not a new 
concept: it was first proposed by Miettinen12 in 1974, 
and is included in the International Epidemiological 
Association’s A Dictionary of Epidemiology,10 and the 
Encyclopedia of Epidemiologic Methods of the Wiley 
Reference Series in Biostatistics.13 PFP is a concept 
closely related to population attributable fraction (PAF), 
defined as the proportion of disease cases or mortality 
cases attributable to a harmful risk factor10 (in other 
words, the proportion that could be averted or prevented 
if a harmful risk factor was eliminated). The appendix 
(pp 1–2) presents graphical depictions of the two concepts. 
PAF would provide an aspirational indicator of what 
could be achieved if all members of the public adopted a 
healthy behaviour. Under most circumstances, such 
widespread adoption would need new investment and 
resources. Conversely, PFP can be used as a positive 
See Online for appendix
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indicator of accomplishment, in terms of how much 
good is being done or has been done by the amount of 
existing beneficial behaviours within a population. As 
such, PFP could be a powerful advocacy tool among 
policy makers, by promoting positive thinking around 
healthy lifestyle behaviours (ie, “look how much benefit 
this behaviour is already providing; let’s create more 
benefit by increasing prevalence of the behaviour 
further”). Although this approach has the risk of causing 
complacency (ie, “the behaviour is already providing 
benefit, why invest in more?”), it could also be a lever to 
protect and maintain services. As such, this could be a 
potentially powerful approach with realistic targets in 
challenging economic climates.
The few studies that have used PFP are not easy to trace 
because of inconsistency in terminology. The terms 
preventive fraction and preventable fraction are variously 
used. We searched the literature for the three different 
terms and found the concept in question has been used 
primarily in oral health, vaccine, and genetic research 
(appendix pp 3–7). We found 12 examples of use that 
quantified the proportion of disease burden or mortality 
burden that had been averted or could have been averted 
due to a current exposure, in relation to lifestyle 
behaviours or their physiological markers. Specifically, 
these studies quantified averted disease or mortality 
burden due to cycling or walking behaviour or fitness, 
fruit and vegetable or vitamin consumption, aspirin 
intake, use of oral contraceptives, sunscreen use, pre-
ventive measures for problem drinking, and inter ventions 
to prevent fractures. All of these studies determined PFP 
with formula 2, presented in the panel. Formula 2 is 
appropriate for scenarios with no confounding factors 
affecting the relationship between exposure prevalence 
and the risk of the disease outcome.14 As the absence of 
confounding is a rarity in the study of lifestyle behaviours, 
formula 3 (panel) is preferable, which addresses the 
potential sources of confounding.11 To the best of our 
knowledge, such an approach has not been applied before 
to global physical activity prevalence.
In this study, we present the first global application of 
PFP, using formula 3, to obtain estimates of the 
proportion and number of premature deaths averted by 
the existing prevalence of physical activity. We obtained 
results for 168 countries with two counterfactual 
scenarios for comparison: no activity in the population, 
and a plausible minimum physical activity prevalence.
Methods
Study design and formulae application
We did a descriptive study to estimate PFP from the 
existing prevalence of physical activity for all-cause 
mortality in 168 countries, using the formula that 
addresses potential confounding factors (formula 3; 
panel). The study protocol including all modifications is 
provided in the appendix (pp 10–11).
Research in context
Evidence before this study
The case for promoting healthy lifestyle behaviours is often 
framed negatively in terms of the harm (disease and death) 
that can be attributed to the absence of healthy behaviours or 
presence of unhealthy behaviours. In an initial literature search 
we aimed to identify examples of use of prevented fraction for 
the population (PFP) relating to lifestyle behaviours, such as 
physical activity, diet and nutrition, alcohol, and smoking. 
Because of the variety of terms used for the concept, we 
searched PubMed and WebofScience for the terms “prevented 
fraction”, “preventive fraction” and “preventable fraction”. 
We searched for papers published from database inception until 
June 12, 2019, without language restrictions. Compared with 
the thousands of studies on disease or mortality burden, we 
identified only 12 published studies that used a version of PFP 
to estimate the proportion of a disease or mortality burden that 
is already being averted or prevented by existing prevalence of 
a healthy behaviour. However, no studies had estimated 
prevented fraction at a global level for total physical activity 
behaviour, nor had the recommended formula for addressing 
confounding been used.
Added value of this study
To the best of our knowledge, this study is the first to quantify 
the effect that existing total physical activity prevalence has 
had on averting premature mortality at the global, regional, 
and country levels. We showed that during 2001–16 across 
168 countries, the median PFP for premature mortality 
averted by existing physical activity prevalence was 15·0%, 
conservatively equating to 3.9 million deaths averted annually. 
We also provided information at a regional level: Africa had the 
highest median PFP, indicating the greatest percentage of 
premature mortality averted by physical activity. The Americas 
had the lowest prevented fraction, closely followed by the 
Eastern Mediterranean region. We further identified a 
tendency towards increased prevented fractions in lower 
income countries compared with higher income countries, and 
in men compared with women.
Implications of all the available evidence
PFP makes the complementary positive case for physical 
activity promotion, focusing on the benefits currently 
accomplished rather than the harms from insufficient 
compliance to recommended levels. This might be a powerful 
advocacy tool in terms of persuading policy makers and wider 
societies that physical activity behaviour has quantifiable 
value, and that existing prevalence should be at least 
preserved.
Articles
www.thelancet.com/lancetgh   Vol 8   July 2020 e922
We defined physical activity as meeting the WHO 
global recommendation of at least 150 min of moderate-
intensity aerobic activity, or 75 min of vigorous-intensity 
activity, or an equivalent combination, throughout one 
week.15 We used population-level, age-standardised and 
harmonised prevalence data on physical activity for the 
years 2001–16 for 168 countries, published by Guthold 
and colleagues,16 to estimate the prevalence of physical 
activity among people who died (Pd), with the formula:
Pd=(Pe × RR) / [(Pe × RR) + (1–Pe)]
In this formula (denoted formula 4; appendix p 9), Pe is 
the prevalence of activity in the population16 and RR is the 
unadjusted relative risk of premature all-cause mortality 
for active individuals of the population, compared with 
inactive individuals. The unadjusted RR was taken from a 
meta-analysis on the association between physical 
inactivity and all-cause mortality by Lee and colleagues.17 
We estimated 95% CIs for Pd using the 95% CIs for Pe in 
this formula.
We used the Pd estimates and adjusted RR, also 
estimated by Lee and colleagues,17 in formula 3 to 
estimate PFP for each country. To estimate the error 
conservatively, we generated distributions for Pd and 
adjusted RR that reflected their 95% CIs. We used a 
binomial distribution for Pd and a normal distribution for 
the natural log of RR.
Subsequently, we did 10 000 Monte-Carlo simulations, 
in which each simulation selected one value from the 
generated Pd and RR distributions, and used them in 
formula 2 (panel). We considered the 10 000 estimates 
produced by the simulations to represent the probability 
distribution of the true PFP. We present the mean of 
these simulated values, with the 95% CIs represented by 
the 2·5th and 97·5th percentiles of the distribution. The 
appendix presents a graphical overview of the method 
(p 12), and the parameters for generated prevalence 
distributions of RR and Pd (pp 13–21).
Mortality averted estimation
To convert PFP into an estimate of number of premature 
deaths averted, we obtained the country-specific number 
of all-cause deaths between the ages of 40–74 years from 
the mortality datasets of the UN World Population 
Prospects tool. We chose this age range to reflect the ages 
at which premature mortality could most plausibly be 
caused by inactivity. We selected mortality data from 
July 1, 2010, to June 30, 2015, which is within the period 
represented by prevalence data, and divided by 5 to 
estimate annual figures. By dividing the observed 
number of deaths by 1 minus the prevented fraction, we 
obtained estimates for the hypothetical total number of 
deaths that would have been observed had there been no 
activity in the population in each nation (ie, a zero 
counterfactual). The total number of premature deaths 
averted was the difference between the observed and 
hypothetical totals. A 95% CI range for the estimate of 
deaths averted was calculated with the lower and upper 
95% CIs of the prevented fraction.
In addition to presenting the country-level estimates, 
we summarised the results by WHO region, and by 2019 
World Bank income classification;18 each of these 
groupings were further subdivided into gender-specific 
results according to the UN mortality datasets. Countries 
without an income categorisation (Cook Islands, Niue, 
occupied Palestinian territory, and Tokelau) were 
classified according to similar neighbouring economies. 
As these groups of countries were small (often <20) and 
the estimates did not typically follow a normal distri-
bution, we present group-level medians and ranges to 
summarise the data; summary values representative of 
all 168 countries are presented in the same way for 
comparability.
For 14 nations we were unable to obtain mortality data; 
these made up less than 0·01% of the world’s population 
(appendix p 22). For these countries, we imputed 
mortality data at ages 40–74 years on the basis of the 
median ratio of deaths to the total population in countries 
in the same WHO region and World Bank income 
Panel: Prevented fraction for the population (PFP)
PFP for a given outcome is defined by the formula: 
In this equation (denoted formula 1), the exposure is protective.10 PFP can also be 
expressed in terms of the prevalence of exposure (Pe) and the relative risk (RR) for 
exposure relative to non-exposure11 (formula 2; appendix p 8): 
PFP=Pe (1–RR)
If potential confounders are present that affect both the prevalence of exposure and the 
risk of disease or mortality, the following formula (denoted formula 3; appendix p 9) is 
recommended,11 where Pd is the prevalence of exposure among disease cases or deceased 
cases:
The proportion estimated by each of these formulae can be interpreted as the reduction 
in the burden of disease or mortality that has occurred due to existing exposure levels, 
compared with if the whole population was unexposed.
For example, in the present study of physical activity and premature mortality, 
we estimated the global median PFP to be 15·0% (range 6·6–20·5). This means that, due 
to existing physical activity levels, the burden of premature mortality is 15% lower than it 
would have been if the whole population was inactive.
The hypothetical denominator is analogous to a situation in which an individual buys a 
discounted item. The individual might pay £0·80 for an item (analogous to the observed 
number of deaths), and be told that they have saved £0·20 (analogous to the estimated 
number of cases that have been averted). The original £1·00 cost of the item was never 
experienced (ie, the hypothetical total number of deaths), but it is the correct 
denominator of the fraction to calculate the percentage saved (20%).
PFP=
incidence rate in the unexposed–incidence rate in the population
incidence rate in the unexposed
PFP=
Pd(1 – RR)
[1 – (1 – RR) (1 – Pd)]
For the UN World Population 
Prospects tool see 
https://population.un.org/wpp/
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categories; these median ratios were multiplied by the 
population of the country without mortality data.
Sensitivity analysis
We did three sensitivity analyses. The first two used 
formula 2: with the unadjusted RR to provide unadjusted 
results, and with the adjusted RR as this was the method 
most commonly used in the literature to date (appendix 
pp 4–7). In the third analysis we used a plausible 
minimum physical activity prevalence counterfactual. 
This comparison attempted to focus on the burden 
averted due to modifiable physical activity prevalence, 
not including the residual levels (ie, individuals who 
would be active regardless of initiatives to promote 
activity). For this comparison, we used the median of the 
lowest observed prevalence of activity from each region. 
We opted for this measure rather than the observed 
lowest prevalence from a single nation because 
environmental and cultural factors vary widely between 
regions and might influence activity levels. Using 
formula 4, we obtained a Pd for this minimum prevalence 
of activity. We adapted formula 3 to allow for a non-zero 
counterfactual, analogous to the population impact 
fraction formulae often used for PAF (denoted formula 5; 
appendix pp 23–25).11 Countries with a prevalence of 
activity lower than the chosen counterfactual value were 
excluded from this analysis. All analyses were done in 
STATA (version 15.1), and forest plots of the data were 
produced in RStudio (version 1.2.5033).
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
For the 168 nations included in this study, the global 
median PFP (determined with formula 3) was 15·0% 
(range 6·6–20·5), equating to 3·9 million (95% CI 
2·5–5·6) premature deaths averted per year (figure, 
table).
The WHO region with the highest PFP was Africa 
(16·6% [12·1–20·5]; equating to 0·5 million deaths 
(95% CI 0·3–0·7) averted annually) and the region with 
the lowest prevented fraction was the Americas (13·1% 
[10·8–16·6]; 0·3 million deaths (95% CI 0·2–0·5) averted 
annually) closely followed by the Eastern Mediterranean 
region (13·2% [6·6–18·9]; 0·2 million deaths (95% CI 
0·1–0·3); figure, table). The countries with the highest 
prevented fractions were Mozambique and Uganda (both 
(Figure continues on next page)
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20·5% [95% CI 14·4–26·2]) and the country with the 
lowest prevented fraction was Kuwait (6·5% [4·0–9·6]; 
appendix pp 26–36). Similar results were observed for 
country-level data classified by gender, with women in 
Niue and men in Tokelau also ranking among the 
populations with the highest prevented fractions 
(appendix pp 37–51). The median prevented fraction in 
countries classified as low income was higher than that in 
Figure: Median PFP estimates and corresponding number of deaths averted
No range is presented for region and income groups with only one country. Countries in each region and income group are shown in the appendix (pp 29–36). Deaths 
averted is for the age range 40–74 years. Number of deaths averted for men and women might not add up to the estimate for both genders because the distributions 
of deaths across men and women are not even, and differences are magnified when multiplied by a derivative of activity prevalence, which also varies considerably by 
gender. PFP=prevented fraction for the population.
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lower-middle-income countries (17·9% [range 12·3–20·5] 
vs 16·5% [12·1–20·3]; figure, table). In turn, lower-middle-
income countries showed a higher prevented fraction 
than countries classified as upper-middle income (14·0% 
[9·5–18·9]) or high income (14·1% [6·6–17·8]). We 
identified a broad pattern of higher median prevented 
fractions for countries of lower income classifications 
within most regions, but the ranges overlapped.
The global median PFP was 14·1% (5·0–20·4) for 
women and 16·0% (7·8–20·7) for men (figure, table, 
appendix pp 37–51). The regional median prevented 
fraction values were between 1·7 and 3·0 percentage 
points lower for women, with the greatest difference in 
the Western Pacific region. The median prevented 
fraction values based on World Bank income classification 
were between 1·5 and 2·0 percentage points lower for 
women, with slightly greater differences between men 
and women in higher income countries than in lower 
income countries. We estimated that 1·5 million (95% CI 
0·9–2·2) annual deaths had been averted for women and 
2·5 million (1·6–3·5) annual deaths for men by existing 
physical activity prevalence across all countries.
Sensitivity analyses with formula 2 produced higher 
estimates of the prevented fractions than our main analy-
sis with formula 3. The global median prevented fraction 
with an unadjusted RR was 22·9% (range 10·5–30·2) and 
with an adjusted RR was 15·6% (7·2–20·6; table). In our 
third sensitivity analysis, we used a counterfactual of the 
median lowest observed prevalence of activity for each 
region, as opposed to 0% of the population meeting the 
physical activity guidelines (formula 5). The median 
lowest prevalence was 54·3%, which corresponded to 
a Pd of 44·7%. Countries that had a prevalence of activity 
lower than this counterfactual value were excluded 
(six countries overall; on gender-specific analyses, nine 
for women and four for men). In this analysis, global 
median prevented fraction was 4·5% (0·3–10·5%), which 
was 11·5 percentage points lower than our previous 
estimate (table). In all sensitivity analyses, the same 
patterns according to region, income classification, and 
gender were evident.
Discussion
Across 168 countries, the median percentage of premature 
mortality averted was 15·0%, conservatively equating to 
3·9 million deaths per year. We identified variations by 
WHO region and World Bank income classification: 
Africa had the highest median PFP, while the Americas 
and Eastern Mediterranean regions had the lowest. 
Countries with low-income classification tended to have 
higher prevented fractions than high-income countries. 
The prevented fractions were higher for men than for 
women, with similar patterns across regions and income 
classifications. To the best of our knowledge, these are the 
first national and global estimates of PFP associated with 
total physical activity. Furthermore, they are the first 
estimates derived from a formula that minimises bias 
from potential confounding in the disease–exposure 
relationship, and from the unequal distribution of activity 
across potential confounders. Use of PFP in this way has 
the potential to create a positive discourse around the 
existing efforts to promote physical activity.
Global differences in the prevented fractions reflect the 
differential prevalence of physical activity; estimations of 
averted deaths also factor in population size and mortality 
rates among people aged 40–75 years. The policy 
implications of the differences in activity prevalence have 
been discussed elsewhere.16 We view the impli cations of 
the present study to be similar across all nations and 
regions: a positive case can be made about existing 
amounts of physical activity, and we believe the results 
and the approach in general are powerful advocacy tools 
for policy makers and other stakeholders in public health. 
Use of PFP could support a positive position on physical 
activity that might be more conducive to political support 
than criticism of current policy, by showing the value of 
existing investment and services, particularly during 
economic hardship. We encourage the incorporation of 
these positive messages into the discourse and advocacy 
around physical activity policy at the global, regional, and 
country levels; for example, via scenario modelling to 
support the WHO Global Action Plan on Physical 
Activity1 and the contribution of physical activity to the 
attainment of the Sustainable Development Goals.19
PFP is a complementary statistic to PAF, with each 
supporting a different approach to framing public health 
advocacy and messaging. PFP compares the current 
situation with the worst-case scenario, whereas PAF 
compares against the best-case scenario. Therefore, if 
activity prevalence increases, we would expect PFP to 
increase (representing increased benefits being accrued), 
and PAF to decrease (representing decreased potential 
for further gains). However, they are not directly 
comparable as proportions because they have different 
denominators: the number of deaths in a hypothetical 
worst-case scenario (PFP), and the number of deaths in 
the current situation (PAF). With that in mind, we 
compare our PFP estimate of 15·0% for physical activity 
with a PAF for physical inactivity, derived with similar 
methods by Ding and colleagues,4 of 6·4%. These 
statistics indicate that, although mortality burden could 
be reduced by 6·4% by increases in activity, if the 
prevalence of activity were to decrease to zero, mortality 
would be 15·0% higher.
Despite PAF being a standard epidemiological 
approach, one caveat, which also applies to PFP, is that 
the counterfactual is the most extreme scenario. Some 
researchers might argue that 0% or 100% of a population 
meeting the global physical activity recommendations is 
implausible; others might debate whether a minimum 
physical activity prevalence exists.20 We therefore also 
estimated PFP using a minimum plausible activity 
prevalence of 54·3% as a counterfactual. The global 
median prevented fraction was 11·5 percentage points 
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lower than when a 0% activity prevalence counterfactual 
was used (4·5% vs 15·0%). Levine21 argued that PAF 
estimates are only meaningful if an intervention can be 
identified that could cause the assumed reduction in 
disease or mortality. The equivalent for PFP would be 
identifying the residual amount of activity that exists 
regardless of intervention.22 However, the burden that 
governments or individual initiatives claim to prevent 
becomes the quantity that they are responsible for 
maintaining, and so we believe these statistics have merit 
as an advocacy tool to start that discussion. Regarding 
the interpretation of these statistics, two further points 
should be considered. Firstly, changes in activity preva-
lence are unlikely to occur independent of other risk 
factors such as obesity, which causes difficulty in 
attributing any burden of mortality entirely to one risk 
factor.23 Secondly, reductions in premature mortality, 
despite being a good health indi cator, do not necessarily 
translate to an extended healthy lifespan or a reduced 
overall burden on the health system.14,24
Assumptions to note in the present study include our 
treatment of physical activity as a binary exposure, 
implying no benefits of undertaking a level of activity 
that is insufficient to meet the global recommendation. 
We know this not to be the case: the greatest reduction 
in mortality risk is evident with initial increases in 
activity at the low end of the activity level spectrum, and 
further benefits are associated with doing more than the 
minimum recommended amount.25,26 Therefore, we 
expect our estimates to be conservative. Our method is 
in line with previous work on the global burden of 
physical activity that used PAF estimates,4,17,27 but differs 
from the approach of Global Burden of Disease (GBD) 
studies, which used a multilevel categorisation of 
physical activity and the equivalent of our formula 2.6,7 
These factors, along with the choices of prevalence and 
mortality data, and of RR values, make a considerable 
difference to estimates of PAF.6,7 For example, estimates 
from two different approaches gave a difference of 
2 million deaths attributable to physical activity.6,7 We 
expect similar variation with regard to PFP and estimated 
number of deaths averted. A 2020 study suggests that 
the magnitude of RR values for mortality associated with 
inactivity are increased when derived from accelerometer-
measured behaviours.28 When global activity prevalence 
estimates are derived from standardised accelerometry 
protocols, the overall effect on estimates of PFP will be 
interesting to reassess.
We chose to be conservative by limiting data to deaths 
occurring between age 40–74 years. This age range 
matches that of many studies used to derive RR, and 
avoids counting causes of death that are not directly 
attributable to physical activity, such as neonatal 
complications or deaths among the oldest age groups 
that stretch the definition of avertable. We considered 
estimating the number of averted deaths in populations 
with non-communicable disease, but the available data 
were not provided for each country by age group. This 
avenue should be considered by future work if the data 
become available, although the events around 
coronavirus disease 2019 have brought into focus the role 
that physical activity might have in promoting immune 
function and preventing deaths from communicable 
disease.29 The number of assumpt ions required, and the 
variability in estimates derived from different data 
sources led Lee and colleagues6 to question whether such 
differences make estimates of disease or mortality 
burden worthless. They concluded that their provision of 
a reference point still had substantial utility. We concur 
that these statistics are helpful indications of pre-
vented, preventable, and attributable disease and 
mortality burdens; a way of translating the results of 
epidemiological or intervention studies into public 
health policy and practice. Some situations such as cross-
country comparisons will favour use of the prevented 
fraction, while others such as within-country advocacy 
might suit the use of the absolute number of deaths 
averted.
In conclusion, we estimated the median global burden 
of premature mortality averted by physical activity to be 
15·0%, conservatively equating to 3·9 million deaths 
annually. We propose use of PFP as a complimentary 
statistic to PAF in promoting healthy lifestyle behaviours, 
to make the cases of both what has been and of what 
could be achieved.
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